Assessing the measure of a new drug: is survival the only thing that matters?

Sargent DJ, Hayes DF. Assessing the measure of a new drug: is survival the only thing that matters? J Clin Oncol. 2008 Apr 20; 26(12):1922-3.

View in: PubMed

subject areas

Antineoplastic Agents
Biomarkers
Breast Neoplasms
Endpoint Determination
Humans
Quality of Life
Randomized Controlled Trials as Topic
Survival Analysis

authors with profiles

Daniel Hayes

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement